36 Dead and Dozens Injured After Pharmaceutical Factory Explosion

A fiery blast at a pharmaceutical factory in southern India has left a scene of utter devastation — with dozens dead, dozens more injured, and search teams still clawing through the rubble for remains.

The explosion ripped through Sigachi Industries’ chemical plant in Sangareddy, Telangana — about 30 miles from Hyderabad — on Monday, June 30, turning the site into a smoldering graveyard of twisted steel, collapsed concrete, and human tragedy.

“It was like a bomb went off,” one survivor told local media. “The roof just vanished. Everything was fire and screams.”

As of Tuesday morning, officials confirmed at least 39 people are dead, with more than 30 others hospitalized, many suffering gruesome burns. The majority of victims were workers on the production floor when the blast hit.

“Bodies were badly burnt and mutilated,” Telangana’s Health Minister Damodar Raja Narasimha told reporters. “We’ve deployed forensic teams for DNA identification. Most are unrecognizable.”

District official P. Pravinya said at least 25 bodies recovered from the rubble have not yet been identified.

And the toll may climb further. More than 140 workers were reportedly inside when the building collapsed completely following the explosion, leaving rescue teams scrambling to find any signs of life under the debris.

Sigachi Industries is not just any factory — it’s one of the world’s largest producers of microcrystalline cellulose, a compound used in the manufacture of everything from tablets and pills to food and cosmetics. The plant was considered a vital cog in India’s booming pharmaceutical sector.

But what sparked the inferno?

That’s still under investigation.

G.V. Narayana Rao, Telangana’s fire and disaster chief, said rescue operations continued overnight. “We are still clearing debris,” Rao said. “Only when we’ve finished will we know if there are more victims underneath.”

Video footage from the scene shows charred walls, blackened machinery, and hazmat-clad workers sifting through ashes.

“It was total chaos,” said a local shopkeeper who witnessed the blast from a distance. “The explosion shook the ground. Then we saw smoke, fire, and people running, screaming.”

Telangana’s state government has launched an official inquiry, forming a high-level committee to investigate what went wrong. In the meantime, Sigachi Industries has halted all operations at the plant for 90 days, citing “severe structural damage” and “irreparable loss to core production facilities.”

The company has yet to publicly explain the cause of the explosion, nor has it responded to American media requests for comment. In a statement filed with the Bombay Stock Exchange, Sigachi promised a “comprehensive site evaluation.”

Though far from American shores, the deadly explosion may have ripple effects in the global pharmaceutical supply chain. Sigachi supplies cellulose to drug makers across the U.S., Europe, and Asia.

“This is more than just a local tragedy — it’s a major hit to global pharma manufacturing,” said one industry analyst. “It underscores the lack of safety oversight in some parts of the supply chain.”

The Biden administration has not issued any comment on the blast, though U.S. trade officials are likely monitoring the situation closely.

India has a long history of industrial accidents — especially in the chemical and pharmaceutical sectors. In 2020, a gas leak at a polymer plant in Visakhapatnam killed 12 and sickened hundreds. Critics argue that safety regulations are too often ignored or poorly enforced.

“The loss of life was preventable,” said a labor union leader in Hyderabad. “This is the cost of putting profit ahead of people.”

As investigators sift through the wreckage and families line up outside hospitals to identify loved ones, one thing is clear: this wasn’t just an explosion. It was a catastrophe born of negligence — and it may not be the last.

“We have to ask ourselves,” said one rescue worker, “how many more people have to die before the system changes?”